UNSPSC 51372127: Oxycodone hydrochloride

This classification denotes an opioid receptor agonist and opioid with the molecular formula C18H21NO4.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier C1ENJ2TE6C, chemically known as 4,5-epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one but more generally known as oxycodone hydrochloride, which bears US NIH Compound Identifier 5284603. European Medicines Agency schedules Oxycodone hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03583MIG.

UNSPSC 51372127 Oxycodone hydrochloride is a Commodity code that does not align with the state and local procurement activity tagged under it. The three recent opportunities in the dataset are unrelated to oxycodone supply: Seminole County, Florida is procuring naloxone and drug deactivation systems for community health support; the Texas Health and Human Services Commission issued a market-research RFI on direct-to-manufacturer prescription programs; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) solicited generic multi-source pharmaceuticals and OTC products through authorized wholesalers. None of these procurements concern oxycodone or controlled-substance supply chains. The code shows little relevant recent activity and suggests a mismatch between the UNSPSC taxonomy assignment and actual state and local buying patterns in this pharmaceutical segment.

The geographic spread of activity under this code spans Florida, Texas, and Minnesota, with multi-state participation through MMCAP (which includes Oregon). The representative opportunities reflect diverse issuing bodies—a county health agency, a state HHS commission, and a cooperative purchasing alliance serving multiple states—but none address oxycodone specifically. Procurement professionals evaluating this code should treat the current data as a signal that oxycodone acquisition through state and local channels is either negligible, classified under different codes, or consolidated through federal or specialized pharmaceutical distribution arrangements outside standard UNSPSC-tagged solicitation processes.